Innostar Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Public

  • Employees
  • 1,173

Employees

  • Stock Symbol
  • 688710

Stock Symbol

  • Share Price
  • $10.50
  • (As of Friday Closing)

Innostar General Information

Description

Shanghai InnoStar Bio-tech Co Ltd is a comprehensive research and development services (CRO) enterprise that specializes in providing biomedical non-clinical research services.

Contact Information

Website
www.innostar.cn
Formerly Known As
Shanghai Yinuosi Biotechnology Co., Ltd.
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 199 Guoshoujing Road
  • Pilot Free Trade Zone
  • Shanghai, 201203
  • China
+86 021
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
SHG
Vertical(s)
Corporate Office
  • 199 Guoshoujing Road
  • Pilot Free Trade Zone
  • Shanghai, 201203
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Innostar Stock Performance

As of 20-Nov-2026, Innostar’s stock price is $10.50. Its current market cap is $1.48B with 141M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10.50 $10.77 $5.69 - $16.70 $1.48B 141M 3.55M $0.08

Innostar Financials Summary

As of 30-Sep-2026, Innostar has a trailing 12-month revenue of $149M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 2,014,908 733,672 518,066
Revenue 149,002 112,820 159,107 146,777
EBITDA 10,814 8,983 31,839 39,252
Net Income 11,358 (4,243) 20,595 27,484
Total Assets 587,266 464,995 441,027 391,536
Total Debt 18,158 16,534 31,658 34,774
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Innostar Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Innostar‘s full profile, request access.

Request a free trial

Innostar Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Innostar ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Innostar’s complete esg history, request access »

Innostar FAQs

  • When was Innostar founded?

    Innostar was founded in 2010.

  • Where is Innostar headquartered?

    Innostar is headquartered in Shanghai, China.

  • What is the size of Innostar?

    Innostar has 1,173 total employees.

  • What industry is Innostar in?

    Innostar’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Innostar a private or public company?

    Innostar is a Public company.

  • What is Innostar’s stock symbol?

    The ticker symbol for Innostar is 688710.

  • What is the current stock price of Innostar?

    As of 20-Nov-2026 the stock price of Innostar is $10.50.

  • What is the current market cap of Innostar?

    The current market capitalization of Innostar is $1.48B.

  • What is Innostar’s current revenue?

    The trailing twelve month revenue for Innostar is $149M.

  • What is Innostar’s annual earnings per share (EPS)?

    Innostar’s EPS for 12 months was $0.08.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process